These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34749618)

  • 1. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.
    Ala M
    Curr Diabetes Rev; 2022; 18(8):e051121197762. PubMed ID: 34749618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
    Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
    PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
    Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
    Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
    Lee HS; Kim SB; Lee HJ; Park SJ; Hong SP; Cheon JH; Kim WH; Kim TI
    Gastrointest Endosc; 2018 Mar; 87(3):688-694.e2. PubMed ID: 28431950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and Colorectal Cancer - A Systematic Review.
    Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
    Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy.
    Jiang S; Lu Q
    J Cancer Res Ther; 2021 Dec; 17(7):1608-1617. PubMed ID: 35381729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus.
    Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N
    Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
    Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
    Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How far along are we in revealing the connection between metformin and colorectal cancer?
    Berkovic MC; Mikulic D; Bilic-Curcic I; Mrzljak A
    World J Gastroenterol; 2021 Apr; 27(14):1362-1368. PubMed ID: 33911461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
    Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
    Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
    Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
    PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic mechanisms underlying antidiabetic drug metformin's chemopreventive effect against colorectal cancer.
    Jaromy M; Miller JD
    Eur J Pharmacol; 2021 Apr; 897():173956. PubMed ID: 33617821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
    Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.